← All organizations
Chiltern International
For profitContributed to NME
Also known as: Chiltern Clinical Research Unit (CCRU). | Chiltern (Early Phase) Limited | Chiltern International Inc. | Chiltern International Ltd. | Chiltern Pesquisa Clinica Ltda | Europe Chiltern International Ltd, Berkshire, UK
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2005Last known activity
Jun 30, 2019
Acquired by LabCorp on Jul 31, 2017
Timeline
1980s
- Jun 1, 1982
Chiltern International— Founded
2010s
- Aug 6, 2015
Theorem Clinical Research— Acquired
- Jul 31, 2017
LabCorp— Acquired By
Drugs by trial phase (49 distinct, 40 trials)
Phase 4 (2 own, 1 via acquisition)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (17 own, 4 via acquisition)
Phase 1 (7 own, 6 via acquisition)
Indications
Studied for
- Acne Vulgaris
- Acquired Immunodeficiency Syndrome
- Atrial Fibrillation
- Autonomic Nervous System Diseases
- Blast Crisis
- Body Weight
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Chronic Disease
- Colorectal Neoplasms
- Communicable Diseases
- Cystic Fibrosis
- Diabetes Mellitus
- Diabetic Neuropathies
- Diarrhea
- Edema
- Familial Primary Pulmonary Hypertension
- Fatty Liver
- Fibrosis
- Heart Diseases
- Heart Failure
- HIV Infections
- Hypertension
- Hypotension
- Hypotension, Orthostatic
- Immunologic Deficiency Syndromes
- Infections
- Influenza, Human
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Diseases
- Lung Diseases
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Macular Edema
- Myelodysplastic Syndromes
- Neutropenia
- Non-alcoholic Fatty Liver Disease
- Pain
- Pancreatic Neoplasms
- Postoperative Pain
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Pure Autonomic Failure
- Respiratory Aspiration
- Syndrome
- Vascular Diseases
- Virus Diseases
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (34)
- NCT03740997CollaboratorPhase 4Jun 30, 2019
- NCT03714815CollaboratorPhase 2Dec 7, 2018
- NCT03749642CollaboratorPhase 2Nov 20, 2018
- NCT03502668CollaboratorPhase 1/Phase 2Jul 27, 2018
- NCT03526835CollaboratorPhase 1May 2, 2018
- NCT03414450CollaboratorPhase 1Apr 25, 2018
- NCT03321981CollaboratorPhase 2Jan 15, 2018
- NCT03202979CollaboratorPhase 2May 16, 2017
- NCT02943785CollaboratorPhase 3Mar 21, 2017
- NCT03102606CollaboratorPhase 2/Phase 3Mar 13, 2017
- NCT02866175CollaboratorPhase 3Feb 24, 2017
- NCT02879760CollaboratorPhase 1/Phase 2Dec 1, 2016
- NCT02924402CollaboratorPhase 1Oct 1, 2016
- NCT02730312CollaboratorPhase 1Aug 1, 2016
- NCT02784444CollaboratorPhase 2Jul 1, 2016
Details
- Founded
- Wilmington, NC, US Jun 1, 1982
- Last known activity
- Jun 30, 2019